News

Canada-reaches-100NBS_900px

100 percent of Canada is Now Screening Infants for Spinal Muscular Atrophy

Western-Canadian-Neuromuscular-Conference

Western Canadian Neuromuscular Conference Accepting Scientific Abstracts for Research Symposium

newborn screening

NMD4C to Prepare Response to Canada’s Drug Agency Newborn Screening Guidelines Discussion Paper

Canadian Neuromuscular Clinical Trial Database

NMD4C Launch Canadian Neuromuscular Clinical Trial Database

2025 clinical and research fellowships competition from NMD4C and MDC.

Fourth Annual Clinical & Postdoctoral Fellowship Competition from NMD4C, MDC to Open Fall 2024

NMD4C wraps up 2023-2024 neuromuscular clinical training curriculum

NMD4C Wraps up Second Year of Training Series for Canadian Neuromuscular Clinical Fellows

2024 NMD4C basic research summer school. Photo of attendees on the right.

NMD4C Host Inaugural Basic Research Summer School

NMD4C investigator Dr Reshma Amin receives funding from CIHR for a grant to develop a framework for real-world evidence for NMDs in Canada

NMD4C Investigator Dr. Reshma Amin Leads Successful CIHR Grant Application to Establish a Framework for Real-World Evidence for Canadian Neuromuscular Diseases

Spinal muscular atrophy outcome measures training registration open for December 3rd event.

Spinal Muscular Atrophy Outcome Measures Workshop (English Language)